Association between germ cell tumours, large numbers of naevi, atypical naevi and melanoma

被引:5
作者
Avril, MF
Chompret, A
Verne-Fourment, L
Terrier-Lacombe, MJ
Spatz, A
Fizazi, K
Bressac-de Paillerets, B
Demenais, F
Théodore, C
机构
[1] Inst Gustave Roussy, Dept Dermatol, Villejuif 94, France
[2] Inst Gustave Roussy, Dept Med, Villejuif 94, France
[3] Inst Gustave Roussy, Dept Pathol, Villejuif 94, France
[4] Inst Gustave Roussy, Dept Biol, Villejuif 94, France
[5] Hop St Louis, INSERM, U358, Paris, France
关键词
atypical naevi; CDKN2A gene; germ cell tumours; melanoma;
D O I
10.1097/00008390-200104000-00005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Identifying groups of subjects at high risk for the development of melanoma is crucial for the early diagnosis of curable tumours. In the present study, we performed a skin examination in a group of 63 patients followed up after treatment of germ cell tumours (GCTs) who were referred to the dermatologist for multiple pigmented cutaneous spots. Forty-nine patients bearing a great number of naevi or atypical naevi were included in the study. Two thin cutaneous melanomas were discovered in two patients. In addition, a third patient had had a conjunctival melanoma since treatment of the GCT. Our study confirms the presence of atypical naevi in a subgroup of GCT patients, who are shown to be at high risk of developing melanoma. Patients harbouring multiple pigmented spots should be referred for a skin examination aimed at early detection of curable melanomas, and should be advised to protect themselves from sun exposure. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 29 条
[1]  
Bartkova J, 2000, INT J CANCER, V85, P370, DOI 10.1002/(SICI)1097-0215(20000201)85:3<370::AID-IJC13>3.0.CO
[2]  
2-A
[3]   SECONDARY NEOPLASMS FOLLOWING TREATMENT OF MALIGNANT GERM-CELL TUMORS [J].
BOKEMEYER, C ;
SCHMOLL, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1703-1709
[4]  
Chaubert P, 1997, AM J PATHOL, V151, P859
[5]   MALIGNANT-MELANOMA OCCURRING AS A 2ND CANCER FOLLOWING PRIMARY GERM-CELL TUMOR IN MALES - REPORT OF 3 CASES [J].
CHUA, HC ;
MORTIMER, PS .
BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (04) :448-449
[6]   2ND NON-GERM CELL MALIGNANCIES AFTER RADIOTHERAPY OF TESTICULAR CANCER WITH OR WITHOUT CHEMOTHERAPY [J].
FOSSA, SD ;
LANGMARK, F ;
AASS, N ;
ANDERSEN, A ;
LOTHE, R ;
BORRESEN, AL .
BRITISH JOURNAL OF CANCER, 1990, 61 (04) :639-643
[7]   The CDKN2A (p16) gene and human cancer [J].
Foulkes, WD ;
Flanders, TY ;
Pollock, PM ;
Hayward, NK .
MOLECULAR MEDICINE, 1997, 3 (01) :5-20
[8]   MELANOCYTIC NEVI AND MELANOMA IN SURVIVORS OF CHILDHOOD-CANCER [J].
GREEN, A ;
SMITH, P ;
MCWHIRTER, W ;
OREGAN, P ;
BATTISTUTTA, D ;
YARKER, ME ;
LAPE, K .
BRITISH JOURNAL OF CANCER, 1993, 67 (05) :1053-1057
[9]   MALIGNANT-MELANOMA IN RENAL-TRANSPLANT RECIPIENTS [J].
GREENE, MH ;
YOUNG, TI ;
CLARK, WH .
LANCET, 1981, 1 (8231) :1196-1199
[10]   ALTERATIONS OF THE P16 (MTS1) GENE IN TESTICULAR, OVARIAN, AND ENDOMETRIAL MALIGNANCIES [J].
HATTA, Y ;
HIRAMA, T ;
TAKEUCHI, S ;
LEE, E ;
PHAM, E ;
MILLER, CW ;
STROHMEYER, T ;
WILCZYNSKI, SP ;
MELMED, S ;
KOEFFLER, HP .
JOURNAL OF UROLOGY, 1995, 154 (05) :1954-1957